Chart courtesy of stockcharts

Sepracor shares were down more than 28% closing at 27.29$ after posted lower-than-expected results and cut its outlook for the year based on stiff competition and lower reimbursement levels for its asthma drug. Looking at the daily chart stock still trading in a clear downtrend in an extreme overbought conditions, so it will probably that during next week stock will rebound some of their losses. So, put SEPR in your watchlist for Monday.

Disclaimer : Trading stocks involves risk, this information should not be viewed as trading recommendations.The charts provided here are not meant for investment purposes and only serve as technical examples.